Relay Therapeutics is trading at $18.45, up +4.32%, with no clear company announcement or event dated September 29 explaining the gain.
- Recent Phase 3-related news was reported September 22, not today.
- The broader market is slightly lower, so its direction does not explain the stock-specific rise.
- No reliable volume or activity information was available.